Pacira BioSciences, Inc. (PCRX) Earnings Per Share (EPS)
Pacira BioSciences, Inc. (PCRX) diluted earnings per share by fiscal period. Track EPS in Excel with MarketXLS.
EPS (Earnings Per Share) Data
| Period | Diluted EPS (USD) |
|---|---|
| 2016-12-31 | -$1.02 |
| 2017-12-31 | -$1.07 |
| 2018-12-31 | N/A |
| 2019-12-31 | -$0.27 |
| 2020-12-31 | $3.41 |
| 2021-12-31 | $0.95 |
| 2022-12-31 | $0.35 |
| 2023-12-31 | $0.91 |
| 2024-12-31 | -$2.15 |
| 2025-12-31 | $0.16 |
How PCRX compares with sector peers
| Symbol | Company | Diluted EPS (latest fiscal year) |
|---|---|---|
| MNKD | MannKind Corporation | $0.02 |
| AKBA | Akebia Therapeutics Inc. | -$0.02 |
| TXMD | TherapeuticsMD Inc. | -$0.05 |
| CERS | Cerus Corporation | -$0.08 |
| HRTX | Heron Therapeutics Inc. | -$0.12 |
These are five companies in the same sector as PCRX with a comparable annual diluted earnings per share. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Pacira BioSciences, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =EarningsPerShare("PCRX")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | PCRX | $23.00 | +0.00% | 0.81M |
| 3 | ||||
| 4 | ||||
| 5 |